Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study

By sjmartinez • May 3, 2024

Rastogi A, Pollack CV Jr, Sánchez Lázaro IJ, Lesén E, Arnold M, Franzén S, Allum A, Hernández I, Murohara T, Kanda E. Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study. Clin Kidney J. 2024 Mar 25;17(5):sfae083. doi: 10.1093/ckj/sfae083. PMID: 38699484; PMCID: PMC11062025.

Tags: Chronic kidney disease, heart failure, hyperkalaemia, Nephrology, Publications, renin–angiotensin–aldosterone system inhibitor, sodium zirconium cyclosilicate

Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis, Fatigue, and Treatment With Avacopan: A Case Series

Schulze C. Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis, Fatigue, and Treatment With Avacopan: A Case Series. Cureus. 2025 Oct 20;17(10):e94987. doi: 10.7759/cureus.94987. PMID: 41280980; PMCID: PMC12631709.

Berger disease redux

Glassock RJ. Berger disease redux. Kidney Int. 2025 Dec;108(6):999-1001. doi: 10.1016/j.kint.2025.09.021. PMID: 41271316.

Shared decision making and decision aids in the management of kidney disease and renal replacement treatment options

Zisman-Ilani Y, Rhee CM, Ammary FA, Kalantar-Zadeh K. Shared decision making and decision aids in the management of kidney disease and renal replacement treatment options.[...]